tiprankstipranks
Advertisement
Advertisement

Adherium Seeks ASX Quotation for 112.7 Million New Shares

Story Highlights
  • Adherium has applied to list 112.7 million new ordinary shares on the ASX, issued on March 20, 2026.
  • The additional quoted shares stem from exercised options or convertible securities, expanding Adherium’s capital base and market liquidity.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Adherium Seeks ASX Quotation for 112.7 Million New Shares

Claim 55% Off TipRanks

The latest announcement is out from Adherium Ltd. ( (AU:ADR) ).

Adherium Ltd. has applied for quotation on the Australian Securities Exchange of 112,724,860 additional ordinary fully paid shares, to be issued on March 20, 2026. The new securities arise from the exercise or conversion of existing options or other convertible instruments and will expand the company’s quoted share base, affecting its capital structure and potentially enhancing liquidity for investors.

The application under ASX Listing Rule Appendix 2A confirms the company’s compliance with relevant listing requirements, supporting the orderly admission of the new shares to trading. This move may influence market perception of Adherium’s financial flexibility and provide existing stakeholders with greater scope for trading, while also signalling continued utilisation of its equity-based funding or incentive arrangements.

The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.

More about Adherium Ltd.

Adherium Ltd., listed on the ASX under the code ADR, is an Australian company whose ordinary fully paid shares are traded on the Australian Securities Exchange. The filing positions the company within the listed equities market but does not specify its industry or core products in this document.

Technical Sentiment Signal: Sell

Current Market Cap: A$13.03M

For detailed information about ADR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1